Veuillez noter que la page demandée n’est pas disponible dans la langue par défaut sélectionnée. Vous utilisez notre plateforme dans une autre langue maintenant.
Global spending growth in selected pharmaceutical major therapeutic classes between 2014 and 2018*
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
8
- Premium Statistic Top therapeutic classes by global pharmaceutical sales 2018 estimates
- Premium Statistic Pharmaceutical industry - sales growth by therapeutic classes
- Basic Statistic Sales of the top pharmaceutical therapeutic areas
- Premium Statistic Sales growth of pharmaceutical therapeutic areas
- Premium Statistic Global pharmaceutical product launches by therapy area 2004-2013
- Basic Statistic Revenue share of Roche's Pharmaceuticals division by therapy area 2013-2023
- Basic Statistic Top pharmaceutical manufacturer vs. top pharmaceutical distributor U.S. 2019
- Premium Statistic Median length of orphan and non-orphan drugs in phase III trial 2015
About the region
7
- Basic Statistic Top pharmaceutical products by sales worldwide 2023
- Premium Statistic Global pharmaceutical pipeline by therapy area 2013-2017
- Basic Statistic AstraZeneca's revenue from Crestor by region 2018-2023
- Premium Statistic Annual growth in global revenue for prescribed orphan drugs 2011-2024
- Premium Statistic Availability of new medicines in selected countries 2013
- Premium Statistic Aspirin tablet price
- Premium Statistic World's top manufacturers of generic drugs based on revenue 2007
Selected statistics
9
- Basic Statistic Merck & Co cash dividends declared 2006-2023
- Basic Statistic Sanofi's total assets 2007-2023
- Premium Statistic Merck & Co - expenditure on research and development 2006-2023
- Basic Statistic Merck & Co total assets 2009-2023
- Premium Statistic Pfizer's revenues in the U.S. and abroad 2009-2023
- Premium Statistic AstraZeneca's expenditure on research and development 2006-2023
- Premium Statistic Johnson & Johnson's number of employees 2004-2023
- Premium Statistic Sales of Johnson & Johnson worldwide 2011-2023, by segment
- Premium Statistic Sales of Johnson & Johnson 2006-2023 by region
Other regions
10
- Premium Statistic Required number of patients for phase III trials of orphan and non-orphan drugs 2015
- Basic Statistic Public drug program spending in Canada by top 10 drug classes 2022
- Premium Statistic New products developed by high-tech companies in China 2022, by industry
- Basic Statistic Number of users of prescription drugs in Norway by ATC main group 2021
- Premium Statistic Parapharmaceuticals sales in Russia 2019-2020, by product
- Premium Statistic ATMP registered trials number globally 1999-2015
- Basic Statistic Export value of medicinal and pharmaceutical products in Denmark 2010-2023
- Premium Statistic Massachusetts' medical cannabis spending 2018-2024
- Basic Statistic Pharmaceutical sector expenditure forecast worldwide by country 2060
- Premium Statistic Latin America: per capita sales of OTC medicines 2017, by country
Related statistics
10
- Basic Statistic Leading orphan drugs in development based on net present value 2024
- Premium Statistic Sanofi number of employees 2009-2023
- Premium Statistic Merck & Co.'s top-selling drugs 2023
- Premium Statistic Eli Lilly and Company's top products based on revenue 2022-2023
- Premium Statistic AstraZeneca's revenue from top product Crestor 2006-2023
- Premium Statistic AbbVie's key product revenues 2022-2023
- Premium Statistic Distribution of Roche's Pharmaceuticals division revenues 2014-2023
- Premium Statistic Roche Group's total sales 2006-2023
- Premium Statistic Roche Group's total sales by division 2013-2023
- Premium Statistic Global spending on medicines 2010-2027
Further related statistics
9
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- Chinese insulin market distribution: leading companies 2011
- U.S. insulin market distribution: leading companies 2011
- CVS Health's total assets 2005-2023
- Walgreens gross profit and net earnings in the U.S. 2005-2023
- Alzheimer's amongst older people in 2050: impact of a 5-year delay in onset
- Projected costs of care for older U.S. Alzheimer sufferers 2010-2050
- Number of employees at Sinopharm 2011-2022
- Annual revenue of Sinopharm 2010-2022
Further Content: You might find this interesting as well
Statistics
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- Chinese insulin market distribution: leading companies 2011
- U.S. insulin market distribution: leading companies 2011
- CVS Health's total assets 2005-2023
- Walgreens gross profit and net earnings in the U.S. 2005-2023
- Alzheimer's amongst older people in 2050: impact of a 5-year delay in onset
- Projected costs of care for older U.S. Alzheimer sufferers 2010-2050
- Number of employees at Sinopharm 2011-2022
- Annual revenue of Sinopharm 2010-2022
IQVIA. (January 31, 2019). Global spending growth in selected pharmaceutical major therapeutic classes between 2014 and 2018* [Graph]. In Statista. Retrieved May 10, 2024, from https://www.statista.com/statistics/279917/sales-growth-of-major-pharmaceutical-therapeutic-classes/
IQVIA. "Global spending growth in selected pharmaceutical major therapeutic classes between 2014 and 2018*." Chart. January 31, 2019. Statista. Accessed May 10, 2024. https://www.statista.com/statistics/279917/sales-growth-of-major-pharmaceutical-therapeutic-classes/
IQVIA. (2019). Global spending growth in selected pharmaceutical major therapeutic classes between 2014 and 2018*. Statista. Statista Inc.. Accessed: May 10, 2024. https://www.statista.com/statistics/279917/sales-growth-of-major-pharmaceutical-therapeutic-classes/
IQVIA. "Global Spending Growth in Selected Pharmaceutical Major Therapeutic Classes between 2014 and 2018*." Statista, Statista Inc., 31 Jan 2019, https://www.statista.com/statistics/279917/sales-growth-of-major-pharmaceutical-therapeutic-classes/
IQVIA, Global spending growth in selected pharmaceutical major therapeutic classes between 2014 and 2018* Statista, https://www.statista.com/statistics/279917/sales-growth-of-major-pharmaceutical-therapeutic-classes/ (last visited May 10, 2024)
Global spending growth in selected pharmaceutical major therapeutic classes between 2014 and 2018* [Graph], IQVIA, January 31, 2019. [Online]. Available: https://www.statista.com/statistics/279917/sales-growth-of-major-pharmaceutical-therapeutic-classes/